We supposed that the parallel expression of these two markers was mainly manifested in the patients without lymph node metastasis, while in those patients with such metastases, the expression of GST-π was low and p53 was high. The gene discussed is TP53; the disease is metastatic malignant neoplasm in the lymph nodes.